Truveta Launches Real-Time AI Analytics Platform to Accelerate Evidence Generation

New updates have been reported about Truveta.

Truveta has introduced Truveta Intelligence, an AI-driven analytics platform that delivers real-time insights from continuously updated real-world clinical data, positioning the company to play a larger role in evidence generation for life sciences, public health, and provider organizations. Built on Truveta Data, the new product analyzes de-identified electronic health records representing more than 130 million patients across care settings and therapeutic areas, enabling customers to query how treatments, patient characteristics, and outcomes are evolving in current practice within minutes rather than months.

For Truveta’s business, Truveta Intelligence expands its offering beyond data access into higher-value, decision-support and analytics capabilities that can influence trial design, commercialization strategy, and care delivery, and is available immediately to existing Truveta Data subscribers. CEO and co-founder Terry Myerson said the platform addresses the time bottleneck in turning data into trusted evidence, while Chief Scientific Officer Johnathan Lancaster emphasized that it provides a scale of clinical experience no individual clinician or single trial can match, and product lead Michael Simonov highlighted the combination of speed, rigor, and transparency as a differentiator that could deepen adoption among health systems and life sciences customers.